Market closedNon-fractional

Verrica Pharmaceuticals/VRCA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Ticker

VRCA

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

West Chester, United States

Employees

100

VRCA Metrics

BasicAdvanced
$324M
Market cap
-
P/E ratio
-$1.75
EPS
1.77
Beta
-
Dividend rate
$324M
1.77
3.169
2.919
3,012.865
3,079.841
-11.90%
-69.22%
-243.35%
39.556
216.78
216.78
-6.495
3.18%
192.99%
-9.44%
9.19%

What the Analysts think about VRCA

Analyst Ratings

Majority rating from 6 analysts.
Buy

VRCA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-534.21% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.8M
100.00%
Net income
-$20M
-17.48%
Profit margin
-534.21%
-58.74%

VRCA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 11.28%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.24
-$0.54
-$0.53
-$0.44
-
Expected
-$0.21
-$0.36
-$0.53
-$0.40
-$0.41
Surprise
14.18%
49.52%
0.38%
11.28%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Verrica Pharmaceuticals stock?

Verrica Pharmaceuticals (VRCA) has a market cap of $324M as of July 06, 2024.

What is the P/E ratio for Verrica Pharmaceuticals stock?

The price to earnings (P/E) ratio for Verrica Pharmaceuticals (VRCA) stock is 0 as of July 06, 2024.

Does Verrica Pharmaceuticals stock pay dividends?

No, Verrica Pharmaceuticals (VRCA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Verrica Pharmaceuticals dividend payment date?

Verrica Pharmaceuticals (VRCA) stock does not pay dividends to its shareholders.

What is the beta indicator for Verrica Pharmaceuticals?

Verrica Pharmaceuticals (VRCA) has a beta rating of 1.77. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Verrica Pharmaceuticals stock

Buy or sell Verrica Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing